However, we have to put the most serious side effects in perspective
The information in this article is not intended to replace any recommendations or relationship with your physician
Major trials conducted in patients with MASLD have reported prevalence rates of 4246%, 1938%, and 1519% for these symptoms, respectively
Hypoglycaemia Low risk for people with diabetes on monotherapy but rises with co-prescribed insulin or sulphonylureas
If the injection is needed (e.g., to replete B or B in a deficient mother), it can be used, but the infant should be observed for any unusual symptoms (though none would be expected from B vitamins, apart from perhaps looser stools if anything)
Amy Patterson, FNP-C Write a description for this list item and include information that will interest site visitors